These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 19023372)

  • 21. Management of multi-drug resistant tuberculosis: practitioner's view point.
    Prasad R
    Indian J Tuberc; 2007 Jan; 54(1):3-11. PubMed ID: 17455417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-tuberculosis chemotherapy].
    Wada M
    Kekkaku; 2007 Oct; 82(10):771-81. PubMed ID: 18018601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases.
    Aziz MA; Wright A
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S258-62. PubMed ID: 16032561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with previously treated tuberculosis no longer neglected.
    Zignol M; Wright A; Jaramillo E; Nunn P; Raviglione MC
    Clin Infect Dis; 2007 Jan; 44(1):61-4. PubMed ID: 17143816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycobacterium tuberculosis in Taiwan.
    Hsueh PR; Liu YC; So J; Liu CY; Yang PC; Luh KT
    J Infect; 2006 Feb; 52(2):77-85. PubMed ID: 16216328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Resistance of Mycobacterium tuberculosis to antituberculotic drugs in Czech Republic in 2003].
    Homolka J; Krejbich F; Havelková M
    Cas Lek Cesk; 2004; 143(12):836-9. PubMed ID: 15730215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB.
    Martinez L; Blanc L; Nunn P; Raviglione M
    Travel Med Infect Dis; 2008 Jul; 6(4):177-81. PubMed ID: 18571104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.
    Sneag DB; Schaaf HS; Cotton MF; Zar HJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1142-6. PubMed ID: 18043453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical research on multi-drug resistant and extensive drug-resistant tuberculosis in Japan].
    Toyota E; Kawabe Y; Yotsumoto H; Sakatani M; Tsuyuguchi K; Maekura R; Fujikawa K; Takashima T; Ogawa K; Yoshiyama T; Sugie T
    Kekkaku; 2008 Dec; 83(12):773-7. PubMed ID: 19172822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug resistant tuberculosis.
    Kamholz SL
    J Assoc Acad Minor Phys; 2002 Apr; 13(2):53-6. PubMed ID: 12362568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extensively drug-resistant tuberculosis: current challenges and threats.
    Jain A; Mondal R
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases.
    Shin S; Guerra D; Rich M; Seung KJ; Mukherjee J; Joseph K; Hurtado R; Alcantara F; Bayona J; Bonilla C; Farmer P; Furin J
    Clin Infect Dis; 2003 Apr; 36(8):996-1003. PubMed ID: 12684912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug resistant tuberculosis: ten years of surveillance in Croatia].
    Katalinić-Janković V; Obrovac M; Simunović A
    Acta Med Croatica; 2004; 58(4):269-73. PubMed ID: 15700682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug resistant tuberculosis: trends and control.
    Prasad R; Gupta N; Singh M
    Indian J Chest Dis Allied Sci; 2014; 56(4):237-46. PubMed ID: 25962197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes.
    Leimane V; Leimans J
    Euro Surveill; 2006; 11(3):29-33. PubMed ID: 16567876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial resistance in tuberculosis: an international perspective.
    van Helden PD; Donald PR; Victor TC; Schaaf HS; Hoal EG; Walzl G; Warren RM
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):759-66. PubMed ID: 17140353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the future trend of drug-resistant tuberculosis in Thailand: assessing the impact of control strategies.
    Nishiura H; Patanarapelert K; Tang IM
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):649-56. PubMed ID: 15689082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tuberculosis drug resistance among new and previously treated pulmonary tuberculosis patients in Cotonou, Benin.
    Affolabi D; Adjagba OA; Tanimomo-Kledjo B; Gninafon M; Anagonou SY; Portaels F
    Int J Tuberc Lung Dis; 2007 Nov; 11(11):1221-4. PubMed ID: 17958985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.